Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis

We declare that we have no competing interests.We also state in the manuscript that 'the study was approved by the Institutional Review Board of the First Affiliated Hospital of Zhejiang University College of Medicine (Hangzhou, China) and was conducted in accordance with the principles of the Declaration of Helsinki'. We completely agree with Wiley's Data Sharing policy, all data associated with this study are present in the paper or the supplementary materials. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.